Core Insights - Limbach Holdings, Inc. (NASDAQ: LMB) has shown significant performance, with the stock increasing as much as 5 times at one point this year [1] Investment Strategy - The investor emphasizes a personal approach to investing, focusing on deep research, independent thinking, and skepticism [1] - The investment strategy includes targeting under-the-radar small caps with asymmetric upside and low-beta stocks that have potential for meaningful growth [1] - The investor also employs a strategy of pairing long positions with targeted short positions to manage risk and capitalize on market mispricing [1]

Core Insights - The article discusses the author's extensive experience in value investing and highlights the focus on analyzing and valuing listed companies in the ASEAN and US regions [1]. Group 1 - The author has two decades of investing experience and has served as a Board member of a Malaysia listed company for several decades [1]. - The blog emphasizes value investing through case studies, providing insights into the investment landscape [1]. - The author has published a value investing book titled "Do you really want to master value investing?" available on Amazon [1].

Core Insights - Hologic (HOLX) is currently viewed as a more attractive investment compared to Idexx Laboratories (IDXX) based on valuation metrics and earnings outlook [3][7]. Valuation Metrics - Hologic has a forward P/E ratio of 15.95, significantly lower than Idexx's forward P/E of 50.91 [5]. - The PEG ratio for Hologic is 2.45, while Idexx's PEG ratio stands at 4.16, indicating Hologic may offer better value relative to its expected earnings growth [5]. - Hologic's P/B ratio is 3.1, compared to Idexx's P/B of 35.04, further suggesting Hologic is undervalued [6]. Earnings Outlook - Hologic has a Zacks Rank of 2 (Buy), indicating an improving earnings outlook, while Idexx has a Zacks Rank of 3 (Hold) [3][7]. - The positive revisions to earnings estimates for Hologic enhance its attractiveness for value investors [3]. Value Grades - Hologic holds a Value grade of B, whereas Idexx has a Value grade of D, reflecting Hologic's superior valuation metrics [6].

Core Insights - The article emphasizes the effectiveness of the Zacks Rank system in identifying winning stocks through earnings estimates and revisions [1] - Value investing is highlighted as a popular and successful strategy across various market conditions, focusing on undervalued stocks [2] Company Analysis: Patrick Industries (PATK) - Patrick Industries is currently rated with a Zacks Rank of 2 (Buy) and has received an "A" grade in the Value category, indicating it is among the strongest value stocks available [3] - The company has a PEG ratio of 1.21, which is lower than the industry average of 1.45, suggesting it may be undervalued relative to its expected earnings growth [4] - PATK's P/CF ratio stands at 11.91, which is also below the industry average of 14.33, further indicating potential undervaluation based on cash flow [5] - Overall, the metrics suggest that Patrick Industries is likely undervalued, making it an attractive value stock at this time [6]

Core Insights - The article emphasizes the importance of earnings estimates and revisions in identifying strong stocks, while also acknowledging that investors have diverse strategies [1] - Value investing is highlighted as a popular method for finding great stocks across various market conditions [2] Company Analysis: Humana (HUM) - Humana is currently rated with a Zacks Rank 2 (Buy) and has received an A grade in the Value category, indicating it is a strong value stock [3] - The company's price-to-book (P/B) ratio is 1.66, which is favorable compared to the industry average of 2.25, suggesting that HUM is relatively undervalued [4] - Humana's price-to-sales (P/S) ratio stands at 0.25, which is lower than the industry average of 0.28, further indicating its potential undervaluation [5] - Overall, Humana's strong value metrics and positive earnings outlook position it as an impressive value stock at this time [6]

Core Insights - The current market environment is characterized by rising major indices driven by passive investing and a mentality where "no price is too high" leading to elevated valuations [1] Group 1: Investment Strategy - A seasoned value investor with nearly 20 years of experience seeks undervalued companies that provide a significant margin of safety, resulting in attractive dividend yields and returns [1] - The investor does not restrict investments to specific sectors or countries but focuses on companies that are well understood and assessed for future growth potential [1] - The investor shows particular enthusiasm for companies with a solid earnings track record trading at less than 8 times free cash flow, which is reflected in the investor's username: 8xfreecash [1]

Core Viewpoint - The comparison between Airbus SE - Unsponsored ADR (EADSY) and Heico Corporation (HEI) indicates that EADSY currently offers better value for investors based on various financial metrics and rankings [1][3][7]. Valuation Metrics - EADSY has a forward P/E ratio of 31.16, significantly lower than HEI's forward P/E of 67.29, suggesting EADSY is more attractively priced [5]. - The PEG ratio for EADSY is 1.36, while HEI's PEG ratio stands at 3.73, indicating that EADSY is expected to grow earnings at a more favorable rate relative to its price [5]. - EADSY's P/B ratio is 7.79 compared to HEI's P/B of 10.5, further supporting the notion that EADSY is undervalued [6]. Earnings Outlook - EADSY has a Zacks Rank of 2 (Buy), reflecting an improving earnings outlook, while HEI has a Zacks Rank of 3 (Hold), indicating a less favorable earnings revision trend [3][7].

Core Viewpoint - The article discusses the challenges and strategies of managing personal investments, particularly in the context of family dynamics and communication about financial losses and gains. Group 1: Investment Performance - The individual initially invested 300,000 in an ETF, earning 10,000 by year-end. However, after switching to Wuliangye, the investment has since lost 12,000 due to a market downturn [1]. - Wuliangye is highlighted as a strong brand in the liquor industry, with a dynamic price-to-earnings (P/E) ratio of 12 and a dividend yield of 4.7%. The company reported a revenue growth of 4.19% and a profit growth of 2.86% in the latest semi-annual report [7]. Group 2: Communication and Family Dynamics - The article emphasizes the importance of discussing investment strategies and potential risks with family members to maintain harmony. It suggests that if a spouse cannot tolerate market volatility, they should not be involved in stock market investments [11]. - It is recommended to establish a clear financial plan that outlines the allocation of funds across different investment types, including conservative and aggressive options, to manage expectations regarding returns and potential losses [12][13].

Core Insights - The Shanghai State-Owned Enterprises 30 Index has been officially launched, focusing on high-quality development characteristics of listed state-owned enterprises in Shanghai, providing a reference for evaluating the effectiveness of state-owned enterprise reforms in the region and supporting value investment in the market [1] Group 1: Index Composition and Methodology - The index is based on policy guidance and state-owned enterprise assessment requirements, utilizing a core logic of "industry selection - stable operation - dividend realization" [1] - The index selection criteria incorporate a unique design based on the central enterprise "one profit and five rates" operational indicator system, which includes total profit, cash return rate, return on equity, and cash dividends per share [1] - The sample stocks are distributed across various industries, with financial-related sectors accounting for 30%, semiconductors for 24%, and transportation for 14%, reflecting regional development characteristics [1] Group 2: Historical Performance and Investment Value - From December 2014 to September 2025, the index achieved an annualized return of 3.81% and a cumulative return of 47.89%, significantly outperforming similar indices [2] - Including dividend income, the annualized return rises to 6.67%, with a cumulative return of 96.51% during the same period [2] - The index is considered to have unique investment value, as its constituent stocks are primarily stable, dividend-paying state-owned enterprise leaders in Shanghai, making it an attractive option for long-term funds seeking stable cash returns [2]

Core Viewpoint - The performance of Lin Yuan's private equity fund products has sparked significant discussion, particularly regarding the substantial losses experienced by some funds, highlighting the challenges faced in the current market environment [1][3][5]. Fund Performance Summary - Lin Yuan Investment No. 173, established in October 2020, has a net value of 0.7598 as of September 26, 2023, reflecting a cumulative loss of 24% since inception and a loss of 3.7% year-to-date [3][4]. - The fund's holder reported a floating loss of 605,200 yuan, equating to a 37.82% loss during the holding period [1]. - Other funds under Lin Yuan's management have also reported negative returns this year, with 19 products underperforming compared to the CSI 300 index, and 6 of these funds showing losses [5]. Market Reactions and Commentary - Financial commentators have expressed mixed sentiments regarding Lin Yuan's investment strategy, with some defending his approach to value investing despite current losses, while others criticize the performance of his funds [1][5]. - Lin Yuan has acknowledged the challenges in the market, particularly in traditional sectors like liquor and pharmaceuticals, and noted that his recent investments in technology stocks were minimal and largely passive [5].